Bio B2B 〉 Selective Search Results
Your Selection Setting ：Clinical Development；
Selective Search Results :
Biotech Companies 18 record(s)；
Senhwa Biosciences, Inc. (6492:TT) identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Developing first-in-class small molecule drugs used in cancer treatments is Senhwa's core value and corporate mission. Headquartered in Taiwan, but with a vital operational base in San Diego, California, the Senhwa Team is well positioned
MEDICALTEK CO., LTD.
MedicalTek Co., Ltd. (MDTK) was established in March, 2016, which had been spun off from Ming Shi Co., Ltd. MDTK devotes to develop and manufacture imaging system for medical used in Minimally Invasive Surgery (MIS). The company is located at Taichung Central Taiwan Science Park, to connect with high-tech companies in central of Taiwan and has the good research relationship with IRCAD/AITS in Changhua
SINEW PHARMA INC.
Sinew Pharma was established in 2014 to aim at the current world urgent important unmet medical needs. The technology platform was based on the modulation of hepatic metabolic enzymes and genes. Among 6 core products, 2 were developed for the treatment of non-alcoholic steatohepatitis (NASH), 4 for the most widely used analgesics acetaminophen related hepatotoxicity.SNP-610 was approved by USFDA
Oneness Biotech Co., Ltd.
We began in 2008 as a government-approved biopharmaceutical company devoted to New Drug Development. In 2011, Oneness became a listed company on the over-the-counter market in Taiwan under the approval of the Securities and Futures Bureau.Today, our vision, our mission and our strategy identify who we are as a company at Oneness.Our VisionOur goal is to become a leading international biotech
SOFIVA GENOMICS is an assembly of authoritative physicians and expert consultants in maternal-fetal medicine, cancer medicine, medical genetics, and clinical medicine. We aspire to act as both clinical physicians and research scientists and closely join fundamental medical research and clinical diagnosis together using translational medicine so as serve our mission and value in medical genetics.Our
Orient Pharma Co., Ltd.
Orient Pharma (OP) was established on Feb 1, 2008. It is focusing on the development and manufactureing of 505(b)(2) new drugs. There are more than 170 employee and 35% are dedicated to R&D. 70% of the employee own master or PhD degrees. Located in Yunlin county in the central of Taiwan, the Yunlin plant obtained the approval for PIC/S GMP from the Taiwan FDA
Meet TaiRxTaiRx, Inc. was founded in 2011 under the strategic alliance of Formosa Laboratories, Inc. and Efficient Pharma Management Corp. to develop a new generation of novel NCE (CVM-1118) for cancer treatment. In 2013, TaiRx started a series of financing and expanded our product pipeline. In addition to cancer treatment, we have expanded our reach to other major diseases. Several products are under
Henlix Biotech Co., Ltd
Henlix Biotech Inc., an innovative biopharmaceutical company, was co-founded by two American biopharmaceutical veterans, Dr. Scott Liu and Dr. Weidong Jiang in October 2010, in Taiwan and expanded its research site in the San Francisco Bay Area. The company specializes in the discovery and development of innovative monoclonal antibody therapeutics, bi-specific antibodies and antibody drug
Protech Pharmaservices Corp.
Protech Pharmaservices Corporation (PPC) was founded in 1997 to meet the growing demands for R&D outsourcing from the Pharmaceutical and Biotech industries in the Asia- Pacific region. Working with its worldwide customers as a leading regional Contract Research Organization (CRO), PPC group provides professional services in “Clinical Research” (Phases I to IV) and “Contract Laboratories&rdquo
SynCore Biotechnology Co., Ltd.
SynCore Biotechnology Co., Ltd (“SynCore”) is a biopharmaceutial company focusing on creating values of new drug by R&D and integration of technology resources. SynCore was established in 2008 and cofounded by Sinphar Group and National Health Research Institute (NHRI). SynCore inherited Sinphar's experiences which have been accumulated for more than 30 years in R&D, manufacturing
TaiHao Medical Inc.
TaiHao Medical is an artificial intelligence company built in 2013 focusing on computer-aided detection and diagnosis. The headquarters is located in Taipei, Taiwan. Our available products are focusing on breast cancer screening to meet the upcoming requirements. Either for images from novel automated breast ultrasound or conventional hand-held ultrasound, the corresponding computer-aided
PharmaEngine, Inc. is a biopharmaceutical company established in February 2003 with funding from TTY Biopharm, National Development Fund and Taiwanese venture capital. We are a networked pharma company that operates according to a combination of "No Research Development Only (NRDO)" model and "Networked Pharma" model. Our company is led by Dr. C. Grace Yeh, and supported
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical
PharmaEssentia Corporation (Taipei Exchange:6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading U.S. biotechnology
MegaPro Biomedical Co., Ltd.
MegaPro Biomedical Co., Ltd. (MegaPro) is a spinoff start-up from Industrial Technology Research Institute (ITRI) which is the largest applied technology R&D institute in Taiwan. The core team has experiences in the field of nanomedicine development for more than 10 years. Since founded on November of 2014, the company is currently focus on developing the proprietary “PEGylated iron oxide
Caduceus Biotechnology Inc.
Caduceus Biotechnology Inc, derived from Industrial Technology Research Institute of Taiwan in 2016, is an innovative company focusing on the design and fabrication of Micro Array Reader and the related customer tailored products. All of our team are highly experienced in the field of optoelectronic and biomedical engineering.Caduceus SpinScan Microarray Scanner HC-BS01 is produced based on a modified
GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.
Gwo Xi Company was founded in 2004. We are developing stem cell therapies that have the potential to transform the lives of people with degeneration diseases and rare diseases. Our production platform is fully compliant with medical regulations (Good Tissue Practice, GTP) in Taiwan. We are committed to continuing to develop stem cell therapy technologies and capabilities. From now, Gwo Xi have 3 clinical